{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:20:30Z","timestamp":1786123230327,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1213\/01.ane.0000297293.84075.74","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T00:02:20Z","timestamp":1236211340000},"page":"143-146","source":"Crossref","is-referenced-by-count":3,"title":["The Effect of a Long\u2013Term Epidural Infusion of Ropivacaine on CYP2D6 Activity"],"prefix":"10.1213","volume":"106","author":[{"given":"Jeroen","family":"Wink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette Th.","family":"Veering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Kruit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton G. L.","family":"Burm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla A. I.","family":"Huledal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla Y.","family":"Ekstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Stienstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack W.","family":"van Kleef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20210902","first-page":"13","article-title":"The relevance of ethnic factors in the clinical evaluation of meds.","author":"Breimer","year":"1994"},{"key":"R2-27-20210902","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMra032424","article-title":"Drug metabolism and variability among patients in drug response","volume":"352","author":"Wilkinson","year":"2005","journal-title":"N Engl Med"},{"key":"R3-27-20210902","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0140-6736(77)91430-1","article-title":"Polymorphic hydroxylation of debrisoquine.","volume":"2","author":"Maghoub","year":"1977","journal-title":"Lancet"},{"key":"R4-27-20210902","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00008571-199608000-00008","article-title":"PCR-based genotyping for duplicated and deleted CYP2D6 genes.","volume":"6","author":"Johansson","year":"1996","journal-title":"Pharmacogenetics"},{"key":"R5-27-20210902","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0378-4347(98)00018-8","article-title":"Determination of ropivacaine in biological samples by gas chromatography with nitrogen-phosphorus detection or mass spectrometry.","volume":"709","author":"Englman","year":"1998","journal-title":"J Chromatogr"},{"key":"R6-27-20210902","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00000542-200701000-00011","article-title":"Pharmacokinetics of ropivacaine in patients with chronic end-stage liver disease.","volume":"106","author":"Jokinen","year":"2007","journal-title":"Anesthesiology"},{"key":"R7-27-20210902","first-page":"529","article-title":"Rapid high-performance liquid chromatographic method for determination of debrisoquine and 4-hydroxy-debrisoquine in urine for CYP2D6 phenotyping.","volume":"9","author":"Svensson","year":"1999","journal-title":"Pharmacogenetics"},{"key":"R8-27-20210902","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1067\/mcp.2002.127111","article-title":"Increased frequency of cytochrome P450 2D6 poor metabolizers among patients with metoprolol-associated adverse effects.","volume":"72","author":"Wuttke","year":"2002","journal-title":"Clinical Pharmacology Ther"},{"key":"R9-27-20210902","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/00912700122009737","article-title":"Evaluation of CYP2D6 oxidation of dextrometorphan and propafenone in a Chinese population with atrial fibrillation.","volume":"41","author":"Chow","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"R10-27-20210902","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0009-9236(96)90211-8","article-title":"The hypoalgesic effect of tramadol in relation to CYP2D6.","volume":"60","author":"Poulsen","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"R11-27-20210902","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s002280050200","article-title":"Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects.","volume":"51","author":"Poulsen","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"R12-27-20210902","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0304-3959(98)00021-9","article-title":"Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation.","volume":"76","author":"Eckhard","year":"1998","journal-title":"Pain"},{"key":"R13-27-20210902","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.0306-5251.2001.01548.x","article-title":"Molecular genetics of CYP2D6: Clinical relevance with focus on psychotropic drugs.","volume":"53","author":"Bertilsson","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"R14-27-20210902","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/clpt.1985.193","article-title":"A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin.","volume":"38","author":"Steiner","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"R15-27-20210902","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/jmg.17.2.102","article-title":"Family and population study of the genetic polymorphism of debrisoquine oxidation in a white Br population.","volume":"17","author":"Evans","year":"1980","journal-title":"J Med Genet"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/01.ane.0000297293.84075.74","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:59Z","timestamp":1786112819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-200801000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1213\/01.ane.0000297293.84075.74","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}